Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma
1997

Low Specificity of PGP9.5 for Detecting Neuroblastoma

Sample size: 22 publication Evidence: moderate

Author Information

Author(s): J Gilbert, MD Norris, GM Marshall, M Haber

Primary Institution: Children's Cancer Research Institute, Sydney Children's Hospital

Hypothesis

The study aims to determine the specificity of PGP9.5 gene transcripts for detecting micrometastatic neuroblastoma.

Conclusion

The study found that PGP9.5 expression is present in a significant number of normal blood and bone marrow samples, suggesting it lacks specificity for detecting neuroblastoma.

Supporting Evidence

  • PGP9.5 was detected in eight out of ten blood samples and seven out of twelve marrow samples.
  • Tyrosine hydroxylase expression was not detected in any normal sample.
  • The presence of PGP9.5 in normal tissues could lead to false-positive results in cancer detection.

Takeaway

The PGP9.5 gene is found in many normal cells, which makes it hard to use for finding cancer cells in blood or bone marrow.

Methodology

The study used nested reverse transcription-polymerase chain reaction (RT-PCR) to evaluate PGP9.5 and tyrosine hydroxylase expression in normal blood and bone marrow samples.

Limitations

The study does not address the potential for false negatives in detecting neuroblastoma due to the presence of PGP9.5 in normal tissues.

Participant Demographics

Samples were obtained from healthy volunteers and patients with non-malignant disease.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication